<DOC>
	<DOCNO>NCT01831869</DOCNO>
	<brief_summary>Subclinical hypothyroidism ( SCH ) common condition affect 3-10 % general population , especially woman older 50 year old . It controversial whether SCH lead increase risk cardiovascular ( CV ) disease whether treatment L-thyroxine revers risk . The present study design evaluate effect L-thyroxine treatment SCH lipid profile , atherosclerosis , endothelial function , serum inflammatory factor adipocytokines .</brief_summary>
	<brief_title>Effect L-Thyroxine Lipid Profiles Atherosclerosis Subclinical Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<criteria>Male female age 18 60 year old ; Diagnosis subclinical hypothyroidism ( elevate serum thyroidstimulating hormone level normal serum free T4 level measure least two time threemonth interval ) ; untreated . Pregnancy lactation woman ; Presence pituitary/hypothalamic disorder , diabetes mellitus endocrinal metabolic disorder ; Presence psychological physical disability , acute infection , cerebrovascular cardiovascular disease , chronic respiratory disease illnesses know alter lipid metabolism ; Taking lipidlowering agent drug know influence thyroid function , blood pressure , heart function bile acid ; Obviously poor compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Subclinical hypothyroidism</keyword>
	<keyword>L-thyroxine</keyword>
	<keyword>Lipid</keyword>
	<keyword>endothelial function</keyword>
	<keyword>inflammatory factor</keyword>
	<keyword>adipocytokine</keyword>
</DOC>